A Phase I Study of PTM-101 as Neoadjuvant Therapy for Borderline Resectable or Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)

  • Pilgrim, Charles (Primary Chief Investigator (PCI))
  • Hawkins, Cheryl-Ann (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date6/08/21 → 31/12/24
View all
View less

Keywords

  • Pancreatic Ductal Adenocarcinoma (PDAC)
  • Gastroenterology
  • Pancreatic cancer
  • Clinical trial